Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ãëàçíûå áîëåçíè > Ôîðóì äëÿ îáùåíèÿ âðà÷åé-îôòàëüìîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 24.11.2008, 20:32
Darina38 Darina38 âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 27.11.2007
Ãîðîä: Tashkent
Ñîîáùåíèé: 3,486
Ïîáëàãîäàðèëè 1,017 ðàç(à) çà 984 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 1
Darina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îáçîð ïî ëå÷åíèþ ãåðïåòè÷åñêèõ ýïèòåëèàëüíûõ êåðàòèòîâ

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Antiviral, interferon, and debridement treatments for herpes simplex eye disease
Herpes simplex is the most common virus acquired by humans, and ocular herpes is a prevalent and recurrent infection. Several treatments, ranging from eye medications to wiping or scraping, aim to shorten the course of herpetic eye disease when infection of the corneal surface, known as a dendrite, occurs. To examine the effectiveness of treatment options, the review author included 99 clinical trials from Europe, North America, Asia, Australia, and Africa that involved 5,363 participants who had a corneal dendrite. Healing rates at one week and two weeks were compared using different treatments, including placebo, antivirals, interferon, and ocular surface removal known as debridement. Placebo was not very effective since only 25% of corneal dendrites healed spontaneously within one week and slightly less than half by two weeks. During the 1960s, the first nucleoside antiviral drug idoxuridine (IDU) was discovered and was shown to lead to faster healing of herpetic corneal infection compared to placebo. Randomized trials subsequently found that antiviral drugs such as trifluridine and acyclovir were better than IDU; about 5 times as many patients healed within one week with trifluridine or acyclovir as with IDU. Further trials showed that trifluridine and acyclovir were equivalently effective and led to healing in two thirds of treated patients by one week and in approximately 90% by two weeks. Ganciclovir gel appeared equivalent to acyclovir ointment. Small trials with bromovinyldeoxyuridine (BVDU) or foscarnet suggested similar effectiveness as trifluridine or acyclovir. In one trial, acyclovir taken by mouth was as good as acyclovir applied to the eye. Interferon was better than placebo and as effective as other antiviral drugs. The combination of interferon-alfa eye drops and either trifluridine or acyclovir resulted in faster healing of dendritic keratitis than treatment with trifluridine or acyclovir alone; 90% of eyes healed within one week with combined interferon-antiviral therapy. Debridement by heat, chemicals, swabbing, or abrasion was commonly used before the development of antiviral drugs; the joint use of debridement and antiviral therapy seemed to speed healing and reduced recrudescent infection. Unfortunately, undue inconsistency among too few studies precluded knowing whether patients who had their infected corneal surface wiped off and then received antiviral treatment healed faster than those treated only with an antiviral medication. This review was limited by the many different therapies that have been studied and could not include 63 other trials that used inadequate methods or reported insufficient information
Objectives
The objective of this review was to compare the effects of various therapeutic interventions for dendritic or geographic HSV epithelial keratitis.
Search strategy
We searched the Cochrane Central Register of Controlled Trials - CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) in The Cochrane Library (Issue 3, 2007), MEDLINE (1966 to September 2007), EMBASE (1980 to September 2007), LILACS (up to September 2007), SIGLE (1980 to September 2007), ZETOC (21 September 2007), BIOSIS (up to 2005), JICT-EPlus (up to 2005), Index Medicus (1960 to 1965), Excerpta Medica Ophthalmology (1960 to 1973), reference lists of primary reports and review articles, and conference proceedings pertaining to ocular virology.
Selection criteriaThis review included comparative clinical trials that assessed one-week or two-week healing rates of topical ophthalmic or oral antiviral agents and or physical or chemical debridement in people with active epithelial keratitis.
Data collection and analysis
The review author extracted data and assessed trial quality. Interventions were compared by the proportions of participants healed at seven days and at fourteen days after trial enrolment.
Main results
This review included data from 99 trials that randomised a total of 5363 participants. The topical application of vidarabine, trifluridine, acyclovir or ganciclovir resulted in a high proportion of participants healing within one week of treatment. Among these antiviral agents, no treatment emerged as significantly better for the therapy of dendritic epithelial keratitis. Insufficient placebo-controlled studies were available to assess debridement and other physical or physicochemical methods of treatment. Interferon monotherapy had a slight beneficial effect on dendritic epithelial keratitis but was not better than other antiviral agents. Interferon was very effective when combined with another antiviral agent such as trifluridine.Authors' conclusions
Currently available antiviral agents are effective and nearly equivalent. The combination of a nucleoside antiviral with either debridement or with interferon seems to speed healing. Future trials of the acute treatment of HSV epithelial keratitis must aim to achieve adequate statistical power for assessing the primary outcome of epithelial healing and should consider the effect of lesion size and other characteristics on treatment response.

Êîììåíòàðèè ê ñîîáùåíèþ:
BASS îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 02.12.2008, 17:00
opto_dive opto_dive âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.09.2008
Ãîðîä: Ðîññèÿ
Ñîîáùåíèé: 2,573
Ñêàçàë(à) ñïàñèáî: 100
Ïîáëàãîäàðèëè 460 ðàç(à) çà 445 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 3
opto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âñå æå ñïðîøó â òåìå, ìîæåò êîìó-òî ïðèãîäèòüñÿ: Äàðèíà, ñêàæèòå Âû èñïîëüçóåòå
Öèòàòà:
Debridement by heat, chemicals, swabbing, or abrasion was commonly used before the development of antiviral drugs; the joint use of debridement and antiviral therapy seemed to speed healing and reduced recrudescent infection.
Èëè ÿ íå â òîì êîíòåêñòå, ïåðåâîä ñòðàäàåò? Âîïðîñ áåç ïîäâîõà, ðàäè íàó÷åíèÿ ñîáñòâåííîãî. Ðàííåå è ñåé÷àñ ïðèìåíÿëè îáðàáîòêó è ïðèæèãàíèå ðàñòâîðîì Éîäà, îòêðîâåííî ãîâîðÿ ýôôåêò õîðîøèé. Âîïðîñ - âñòðå÷àëàñü ëè ãäå òàêàÿ òåõíèêà îïèñàííàÿ â ðóêîâîäñòâàõ (ñîâðåìåííûõ â Ðîññèè è çà ðóáåæîì)? Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 02.12.2008, 17:47
Darina38 Darina38 âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 27.11.2007
Ãîðîä: Tashkent
Ñîîáùåíèé: 3,486
Ïîáëàãîäàðèëè 1,017 ðàç(à) çà 984 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 1
Darina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Òóøèðóþ èíôèëüòðàò Áåòàäèíîì ïîñëå ìåñòíîé àíåñòåçèè, íî ýïèòåëèé íå ñíèìàþ, êàê-òî îáõîæóñü ïîêà áåç ýòîãî
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 10.08.2009, 17:29
opto_dive opto_dive âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.09.2008
Ãîðîä: Ðîññèÿ
Ñîîáùåíèé: 2,573
Ñêàçàë(à) ñïàñèáî: 100
Ïîáëàãîäàðèëè 460 ðàç(à) çà 445 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 3
opto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
èç [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Î÷åíü âàæíî îòñëåæèâàòü, íàñêîëüêî ýôôåêòèâíî ëå÷åíèå, ïîñêîëüêó íàçíà÷åíèå ñòåðîèäîâ ïðè îòñóòñòâèè óëó÷øåíèÿ ìîæåò ñïðîâîöèðîâàòü ðÿä îñëîæíåíèé....

Ïðîô. Christopher J. Rapuano... (Ôèëàäåëüôèÿ, ÑØÀ), ñîãëàñåí ñ íåîáõîäèìîñòüþ ïðîâîäèòü â òàêèõ ñëó÷àÿõ êîìáèíèðîâàííîå ëå÷åíèå è ïðåäóïðåæäàåò êëèíèöèñòîâ, ÷òî ñòåðîèäû íàäî íàçíà÷àòü êðàéíå îñòîðîæíî, îñîáåííî ïðè àêòèâíîì ïðîöåññå (íàïðèìåð, òàêîì êàê äðåâîâèäíûé êåðàòèò).

Åñëè âîñïàëèòåëüíûé ïðîöåññ íà ôîíå ñòðîìàëüíûõ êåðàòèòîâ íå ðåöèäèâèðóåò, òî èíñòèëëÿöèè ñòåðîèäîâ ìîæíî ïðåêðàùàòü, íî åùå íå ìåíüøå òðåõ ìåñÿöåâ ñîõðàíÿåòñÿ âûñîêèé ðèñê ðåöèäèâà ñ èñõîäîì â áîëåå ãðóáûå ïîìóòíåíèÿ. Îòìåíÿòü ìåñòíûå ñòåðîèäû íàäî î÷åíü ïîñòåïåííî, èíîãäà ýòî çàíèìàåò 6-12 ìåñÿöåâ.  íåêîòîðûõ ñëó÷àÿõ ïîëíîñòüþ îòêàçàòüñÿ îò ñòåðîèäîâ íå óäàåòñÿ, è òîãäà ïàöèåíòà îñòàâëÿþò íà ìèíèìàëüíîì ðåæèìå èíñòèëëÿöèé (2 ðàçà â íåäåëþ).
Êîëëåãè, êòî, êàê è êîãäà íàçíà÷àåò ñòåðîèäû ïðè ãåðïåòè÷åñêèõ êåðàòèòàõ?
Åñòü äîñòóïíûå ïðåïàðàòû Trifluridine â Ðîññèè? Ñ óâàæåíèåì, çàðàíåå ñïàñèáî çà îòâåòû..
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 12.08.2009, 07:18
Àâàòàð äëÿ ainakoz
ainakoz ainakoz âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.12.2008
Ãîðîä: Ðîññèÿ, ×åëÿáèíñê
Ñîîáùåíèé: 2,442
Ñêàçàë(à) ñïàñèáî: 24
Ïîáëàãîäàðèëè 462 ðàç(à) çà 440 ñîîáùåíèé
ainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Darina38 Ïîñìîòðåòü ñîîáùåíèå
Òóøèðóþ èíôèëüòðàò Áåòàäèíîì ïîñëå ìåñòíîé àíåñòåçèè, íî ýïèòåëèé íå ñíèìàþ, êàê-òî îáõîæóñü ïîêà áåç ýòîãî
È ïðàâèëüíî îí ñàì ñëàçèò ... ß òóøèðóþ ðàñòâîðîì èîäà. Ñîãëàñåí ñ opto_dive, õîðîøèé ýôôåêò. À ïîòîì, ñêðåïÿ ñåðäöå, íàçíà÷àþ àíòèáèîòèê ñ äåêñàìåòàçîíîì â êàïëÿõ è àöèêëîâèð âíóòðü.
Âñåãäà áûë õîðîøèé ýôôåêò.
Ñåé÷àñ åñòü ñ ãåðïåòè÷åñêèì êåðàòîóâåèòîì ìîëîäîé ÷åëîâåê, (ãåïàòèòû B,C + ÂÈ×-èíôåêöèÿ) Âîò åãî òî÷íî óæå íèêàêîé èîä è íèêàêèå ïðîòèâîâèðóñíûå ïðåïàðàòû íå áåðóò. Ðîãîâèöà - òîòàëüíûé èíôèëüòðàò ãèïîïèîí â êàìåðå, êðàñíûé ãëàç. È ñòàöèîíàðíî ëå÷èëè åãî, è äåêñàìåòàçîí êîëîëè. Òåì íå ìåíåå ïðîäîëæàåò áîëåòü. Âòîðîé ãëàç - çäîðîâûé, çðåíèå 100%
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 12.08.2009, 19:02
Rameyka Rameyka âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.12.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,431
Ñêàçàë(à) ñïàñèáî: 30
Ïîáëàãîäàðèëè 545 ðàç(à) çà 535 ñîîáùåíèé
Rameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
"Ðîãîâèöà - òîòàëüíûé èíôèëüòðàò ãèïîïèîí â êàìåðå, êðàñíûé ãëàç. È ñòàöèîíàðíî ëå÷èëè åãî, è äåêñàìåòàçîí êîëîëè. Òåì íå ìåíåå ïðîäîëæàåò áîëåòü."
âàõ! ×å äåëàòü áóäåòå? - îé-å-îé...ñî÷óâñòâóþ!
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 12.08.2009, 19:55
Dr-vasiliY Dr-vasiliY âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 06.10.2006
Ãîðîä: Îðåë
Ñîîáùåíèé: 618
Ñêàçàë(à) ñïàñèáî: 14
Ïîáëàãîäàðèëè 135 ðàç(à) çà 131 ñîîáùåíèé
Dr-vasiliY ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr-vasiliY ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr-vasiliY ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr-vasiliY ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr-vasiliY ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ainakoz Ïîñìîòðåòü ñîîáùåíèå
À ïîòîì, ñêðåïÿ ñåðäöå, íàçíà÷àþ àíòèáèîòèê ñ äåêñàìåòàçîíîì â êàïëÿõ è àöèêëîâèð âíóòðü.
À çà÷åì ñòåðîèäû, òåì áîëåå ïðè íåïîëíîöåííîì ýïèòåëèè? Ñàì íå íàçíà÷àþ, õîòåëîñü áû ïîíÿòü ñìûñë. Áåç ñòåðîèäîâ òàê æå íàáëþäàþ õîðîøóþ äèíàìèêó.
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 13.08.2009, 06:12
Àâàòàð äëÿ ainakoz
ainakoz ainakoz âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.12.2008
Ãîðîä: Ðîññèÿ, ×åëÿáèíñê
Ñîîáùåíèé: 2,442
Ñêàçàë(à) ñïàñèáî: 24
Ïîáëàãîäàðèëè 462 ðàç(à) çà 440 ñîîáùåíèé
ainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
To Vasiliy: Áûñòðåå ãëàç óñïîêàèâàåòñÿ. Äåêñàìåòàçîí ÿ ïðèñîåäèíÿþ óæå ïîñëå ýïèòåëèçàöèè.

To Rameyka: Äà òàì âîîáùå øâàõ! Ïàíîôòàëüìèò... Íàñ÷¸ò òîãî ÷òî äåëàòü áóäó - à íè÷åãî. Íå÷åãî áûëî íàðêîìàíèòü! ß åãî íàïðâëÿë â ãëàçíîå îòäåëåíèå áîëüíèöû ñêîðîé ìåíäèöèíñêîé ïîìîùè. Òàì åãî 10 äíåé ïðîëå÷èëè áåç ýôôåêòà (âîò êàê ðàç òåì ñàìûì äåêñàìåòàçîíîì ïàðàáóëüáàðíî) à ïðè âûïèñêå ñêàçàëè "ýòî ñîñòîÿíèå ëå÷èòñÿ äîëãî, ãîäàìè..." è ñ Áîãîì äîìîé îòïðàâèëè. Âîò îí òåïåðü ñïîêîéíåíüêî õîäèò, äà êàïàåò êàïëè ëåâîìèöåòèíîâûå... Îñîáî íå íàïðÿãàåò ïðèõîäèò ðàç â 2 íåäåëè. Ãëàç íè êðàñíåå íè ñïîêîéíåå... ñòàáèëüíî, îäèíàêîâî. Äóìàþ, ÷òî íà ñóáàòðîôèþ ïîñòåïåííî ñàì óéä¸ò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 13.08.2009, 20:34
Rameyka Rameyka âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.12.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,431
Ñêàçàë(à) ñïàñèáî: 30
Ïîáëàãîäàðèëè 545 ðàç(à) çà 535 ñîîáùåíèé
Rameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRameyka ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ñòðåìíî êàê-òî... íà ïðîøëîé íåäåëå ïàíîôòàëüìèò ó àëêîãîëè÷êè - ïðîíèêàþùåå 3 äíåâíîå èíô. ðàíåíèå - ýíó - òàì òàêîå âûïèðàëî èç îðáèòû - ïðè îïåðàöèè ìûøöû ïî 16 ìì, ïîñëå ýíó - ñïîêîéíÿê - ïðàâäà ïðè ñïèäå - ñâåðòûâàåìîñòü è âñå äåëà...îé-þøêè...
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 16.08.2009, 16:57
opto_dive opto_dive âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.09.2008
Ãîðîä: Ðîññèÿ
Ñîîáùåíèé: 2,573
Ñêàçàë(à) ñïàñèáî: 100
Ïîáëàãîäàðèëè 460 ðàç(à) çà 445 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 3
opto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ainakoz Ïîñìîòðåòü ñîîáùåíèå
Ïàíîôòàëüìèò... Íàñ÷¸ò òîãî ÷òî äåëàòü áóäó - à íè÷åãî. Íå÷åãî áûëî íàðêîìàíèòü! ß åãî íàïðâëÿë â ãëàçíîå îòäåëåíèå áîëüíèöû ñêîðîé ìåíäèöèíñêîé ïîìîùè. Òàì åãî 10 äíåé ïðîëå÷èëè áåç ýôôåêòà (âîò êàê ðàç òåì ñàìûì äåêñàìåòàçîíîì ïàðàáóëüáàðíî) à ïðè âûïèñêå ñêàçàëè "ýòî ñîñòîÿíèå ëå÷èòñÿ äîëãî, ãîäàìè..." è ñ Áîãîì äîìîé îòïðàâèëè. Âîò îí òåïåðü ñïîêîéíåíüêî õîäèò, äà êàïàåò êàïëè ëåâîìèöåòèíîâûå..
Ñêàæèòå ôóíêöèè - íîëü? À ïî÷åìó íå ñêàæèòå êàïàòü äåêñàìåòàçîí 1êàï - 3 ð/äåíü ïîä êîíòðîëåì ÂÃÄ íà ìåñÿö? Ýòî ñëîæíî, èëè íåëüçÿ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 17.08.2009, 21:39
Àâàòàð äëÿ ainakoz
ainakoz ainakoz âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 23.12.2008
Ãîðîä: Ðîññèÿ, ×åëÿáèíñê
Ñîîáùåíèé: 2,442
Ñêàçàë(à) ñïàñèáî: 24
Ïîáëàãîäàðèëè 462 ðàç(à) çà 440 ñîîáùåíèé
ainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåainakoz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äà íåò, ñâåò âèäèò. Äåêñàìåòàçîí êàïàåò, ÈÌÕÎ êîíòðîëü ÂÃÄ óæå íå íóæåí... Òàì âîîáùå íè÷åãî êðîìå ãåðîèíà ïîõîæå íå íóæíî... È çðåíèå òîæå.  âåíó ñ îäíèì ãëàçîì åù¸ ëó÷øå ìåòèòüñÿ...
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 22.08.2009, 22:22
opto_dive opto_dive âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.09.2008
Ãîðîä: Ðîññèÿ
Ñîîáùåíèé: 2,573
Ñêàçàë(à) ñïàñèáî: 100
Ïîáëàãîäàðèëè 460 ðàç(à) çà 445 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 3
opto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåopto_dive ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äðóãîé âîïðîñ, â îòíîøåíèå òåõ êîìó ýòî (çðåíèå..) íóæíî - íåäàâíî ïðîñìàòðèâàë è âîçíèê âîïðîñ íå ñ ýòèì ëè áûëè äâà ïàöèåíòà (ó êàæäîãî ïî îäíîìó ãëàçó ñ äèñòðîôèåé ðîãîâèöû, ðàçâèâøåéñÿ â ðåçóëüòàòå "íåÿñíîãî êîðîòêîãî âîñïàëåíèÿ" çà îãðàíè÷åííûé ïåðèîä âðåìåíè).
È â ðåçóëüòàòå íåò íèêàêèõ ïðèçíàêîâ ïîñòóâåàëüíûõ èçìåíåíèé, ÂÃÄ â ïðåäåëàõ íîðìû ñ êîëåáàíèÿìè... íî êàðòèíêè ëó÷øå íå ïðåäñòàâèòü, ýòî ïðÿìî îäèí â îäèí ñ ýòèìè ãëàçàìè - êàðòèíêà Â, òîëüêî ãëàçà çíà÷èòåëüíî áîëåå ñïîêîéíûå. (íèêàêîé õèðóðãèè íå áûëî).
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Figure 3.4 Pretreatment stromal keratitis and endotheliitis (A) with microcystic corneal edema (B). Posttreatment with topical steroids and oral acyclovir (C). èç êíèãè Editors: Kertes, Peter J.; Johnson, T. Mark
Title: E.-B. Eye Care, 1st Edition

Èëè ìîæåò åñòü ïðè÷èíû, êîòîðûå "áîëåå ðàñïðîñòðàíåíû" ÷òîáû ïðèîáðåñòè òàêóþ äèñòîôèþ â ïîæèëîì âîçðàñòå.

- ìîæåò ãåðïåñ áûòü ñïåöèôè÷íîé ïðè÷èíîé òàêîé äèñòðîôèè, èëè ýòî åäèíè÷íûå ñëó÷àè.
P.S. åùå âîïðîñ ðàçíûå àçàïåíòàöÈíû èëè ðàñòâîðû ïðîïîëèñà ìîãëè áûòü ïðè÷èíîé ýòèõ ñëó÷àåâ, äðóãèõ õèìèêàòîâ âðîäå íå áûëî (ñïèðòîì, éîäîì âðîäå íå êàïàëè, íî ëå÷èëè âðåìåíàìè..), äóìàþ íà ñ÷åò ìåäà íà ÿáëîêàõ.. Âàøè ïðåäëîæåíèÿ? Îäíó ðîãîâèöó íàêðûëè ñèëèêîí-ãèäðîãåëåì (áóëëåçíîñòü, ðîã.ñèíäðîì), äðóãàÿ òàê æèâåò. Çàðàíåå ñïàñèáî..
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 23.08.2009, 20:21
Darina38 Darina38 âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 27.11.2007
Ãîðîä: Tashkent
Ñîîáùåíèé: 3,486
Ïîáëàãîäàðèëè 1,017 ðàç(à) çà 984 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 1
Darina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDarina38 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñêîðåå âñåãî ãåðïåñ. Îí ìíîãîëèê. Åñëè ìíå íà ïðèåìå ïîïàäàåòñÿ äðåâîâèäíûé êåðòàòèò- ÿ ðàäóþñü òàêîìó ïðîñòîìó ïðîÿâëåíèþ ÂÏÃ.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 05:32.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.